Treatment of Preeclampsia: Current Approach and Future Perspectives

Current Hypertension Reports

Volumn 16, Issue 9, 2014, Pages 1-6

  Berzan, Ecaterina ^a   Doyle, Ross ^a   Brown, Catherine M ^a  

^a WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

Antihypertensives; Guidelines; Hypertension; Low dose aspirin; Magnesium sulphate; Preeclampsia; Pregnancy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE; FEMALE; HUMAN; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; RISK FACTORS;

EID: 84939874591     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0473-5     Document Type: Review

References (44)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–22.
2. ACOG Committee on Practice Bulletins. ACOG practice bulletin. Chronic hypertension in pregnancy. Obstet Gynecol. 2001;98(1 suppl):177–85.
3. Practice ACoO. Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99(1):159–67.
4. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014. These are important recent statistics on causes of maternal death due to hypertension in pregnancy.
5. Brown CM, Garovic VD. Drug treatment of hypertension in pregnancy. Drugs. 2014;74(3):283–96. doi:10.1007/s40265-014-0187-7.
6. Magee LA, Helewa M, Moutquin JM, von Dadelszen P, Hypertension Guideline Committee, Society of Obstetricians and Gynaecologists of Canada. Treatment of the hypertensive disorders of pregnancy. In: Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Canada: JOGC J d’Obstet Gynecol Can JOGC. 2008;30(3 Suppl 1):S24–36.
7. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357. doi:10.1097/01.hjh.0000431740.32696.cc. This provides comprehensive guidelines on the treatment of hypertension in pregnancy.
8. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–87. doi:10.1097/HJH.0b013e3281fc975a.
9. Excellence NIfHaC. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: NICE 2010. Report No.: Contract No.: CG107.
10. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol. 2009;49(3):242–6. doi:10.1111/j.1479-828X.2009.01003.x.
11. Homer CS, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens. 2008;26(2):295–302. doi:10.1097/HJH.0b013e3282f1a953.
12. Pettit F, Brown MA. The management of pre-eclampsia: what we think we know. Eur J Obstet Gynecol Reprod Biol. 2012;160(1):6–12. doi:10.1016/j.ejogrb.2011.09.049.
13. Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: risk factors and causal models. Best Pract Res Clinical Obstet Gynaecol. 2011;25(3):329–42.
14. Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24:147–58. doi:10.1152/physiol.00043.2008.
15. Hertig A, Liere P. New markers in preeclampsia. Clin Chim Acta Int J Clin Chem. 2010;411(21–22):1591–5. doi:10.1016/j.cca.2010.07.020.
16. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631–44. doi:10.1016/S0140-6736(10)60279-6.
17. Cetin I, Huppertz B, Burton G, Cuckle H, Gonen R, Lapaire O, et al. Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta. 2011;32(Suppl):S4–16. doi:10.1016/j.placenta.2010.11.022.
18. American College of Obstetricians and Gynecologists, Task Force on Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31. doi:10.1097/01.AOG.0000437382.03963.88. This is an important recent statement from ACOG on hypertension in pregnancy.
19. Podymow T, August P. Antihypertensive drugs in pregnancy. Semin Nephrol. 2011;31(1):70–85. doi:10.1016/j.semnephrol.2010.10.007. This provides a comprehensive review of antihypertensives used in pregnancy.
20. Magee LA. Drugs in pregnancy. Antihypertensives. Best Pract Res Clin Obstet Gynaecol. 2001;15(6):827–45. doi:10.1053/beog.2001.0232.
21. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;11, CD000025. doi:10.1002/14651858.CD000025.pub2.
22. Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2010;12, CD000127. doi:10.1002/14651858.CD000127.pub2.
23. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;2, CD004659. doi:10.1002/14651858.CD004659.pub2.
24. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010;8, CD001059. doi:10.1002/14651858.CD001059.pub3.
25. European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97. doi:10.1093/eurheartj/ehr218. These guidelines provide up-to-date information on the management of cardiovascular disease in pregnancy.
26. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92(9):3517–22. doi:10.1210/jc.2007-0718.
27. De-Regil LM, Palacios C, Ansary A, Kulier R, Pena-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2012;2, CD008873. doi:10.1002/14651858.CD008873.pub2.
28. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362(14):1282–91. doi:10.1056/NEJMoa0908056.
29. Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol. 1993;168(3 Pt 1):915–22.
30. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev. 2006;3, CD003402. doi:10.1002/14651858.CD003402.pub2.
31. Olsen SF, Osterdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. Eur J Clin Nutr. 2007;61(8):976–85. doi:10.1038/sj.ejcn.1602609.
32. Mostello D, Jen Chang J, Allen J, Luehr L, Shyken J, Leet T. Recurrent preeclampsia: the effect of weight change between pregnancies. Obstet Gynecol. 2010;116(3):667–72. doi:10.1097/AOG.0b013e3181ed74ea.
33. Maggard MA, Yermilov I, Li Z, Maglione M, Newberry S, Suttorp M, et al. Pregnancy and fertility following bariatric surgery: a systematic review. JAMA J Am Med Assoc. 2008;300(19):2286–96. doi:10.1001/jama.2008.641.
34. Meher S, Duley L. Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev. 2006;2, CD005939. doi:10.1002/14651858.CD005939.
35. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database Syst Rev. 2005;4, CD003514. doi:10.1002/14651858.CD003514.pub2.
36. Duley L, Henderson-Smart D, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev. 2005;4, CD005548. doi:10.1002/14651858.CD005548.
37. Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;2, CD006490. doi:10.1002/14651858.CD006490.
38. Dorniak-Wall T, Grivell RM, Dekker GA, Hague W, Dodd JM. The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials. J Hum Hypertens. 2014;28(4):230–5. doi:10.1038/jhh.2013.100. This recent paper provides some insight into possible future therapies.
39. Wang K, Ahmad S, Cai M, Rennie J, Fujisawa T, Crispi F, et al. Dysregulation of hydrogen sulfide producing enzyme cystathionine gamma-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation. 2013;127(25):2514–22. doi:10.1161/CIRCULATIONAHA.113.001631.
40. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension. 2011. doi:10.1161/hypertensionaha.111.169755.
41. Walsh SK, English FA, Crocker IP, Johns EJ, Kenny LC. Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia. Br J Pharmacol. 2012;166(7):2109–16. doi:10.1111/j.1476-5381.2012.01906.x.
42. Craici IM, Wagner SJ, Weissgerber TL, Grande JP, Garovic VD. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int. 2014. doi:10.1038/ki.2014.17. This is a comprehensive review of podocyte injury in preeclampsia.
43. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke J Cereb Circ. 2014;45(5):1545–88. doi:10.1161/01.str.0000442009.06663.48. These recommendations provide important guidance for stroke prevention in women with a history of preeclampsia.
44. Mitka M. New guidelines focus on preventing stroke in women. JAMA J Am Med Assoc. 2014;311(10):1003–4. doi:10.1001/jama.2014.1775.